Serina Therapeutics Inc.

SER | AMEX

Price Alert Chart Builder DCF Calculator

$2.33

+$0.02 (+0.87%)

Sep 22, 2026, 12:32 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $34.64M

Enterprise Value $11.74M

Beta 0.03

Average Volume 76.76K

Shares Outstanding (Diluted) 16.39M

Shares Change YoY 63.78%

Institutional Ownership 12.22%

Exchange AMEX

ISIN US81751A1088

Price Performance

Price Change 1M -16.6%

Price Change 3M 20.3%

Price Change 6M -23.8%

Price Change YTD 11.1%

Price Change 1Y -54.6%

Price Change 3Y -91.4%

Price Change 5Y -93.3%

1M CAGR (ann.) -3.8%

1Y CAGR (ann.) -48.8%

5Y CAGR (ann.) -42.1%

All-Time CAGR -38.0%

Valuation

PE Ratio -1.23

Forward PE N/A

PEG Ratio 0.03

Forward PEG 0.05

PS Ratio N/A

Forward PS N/A

PB Ratio 1.85

P/FCF Ratio -1.64

P/Adj. FCF Ratio -1.43

P/OCF Ratio -1.79

EV/Sales N/A

EV/EBIT -0.53

EV/EBITDA -0.53

EV/FCF -0.55

Earnings Yield -81.4%

FCF Yield -61.1%

Adj. FCF Yield -70.0%

Financial Health

Net Cash $22.9M

Total Debt $122K

Cash & Short-Term Investments $23.02M

Total Assets $25.81M

Current Ratio 6.65

Quick Ratio 6.65

Debt / Equity Ratio 0.17

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -173.24

Interest Coverage -117.72

Altman Z-Score -3.08

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -14.5%

Returns

Return on Assets -82.0%

Return on Equity -222.4%

Return on Invested Capital -116.4%

Return on Capital Employed -116.4%

Return on Tangible Assets -82.0%

Historical Growth (CAGR)

Revenue CAGR 3Y -144.0%

Revenue CAGR 5Y -0.1%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 47.5%

EPS CAGR 5Y 41.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -33.1%

FCF CAGR 5Y -33.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y 13.1%

Revenue Growth Next 3Y N/A

Earnings Date Nov 17, 2026

EPS Estimate (next Q) -$0.34

EPS Growth Est (next Q) -24.9%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8

Price Target Upside 246.3%

Cash Flow

Operating Cash Flow $-21.14M

Free Cash Flow $-21.17M

Adj. Free Cash Flow $-24.25M

FCF Per Share -$1.29

OCF Per Share -$1.29

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-7.07M

Operating Income $-25.66M

EBITDA $-22.15M

Net Income $-21.18M

EPS (Diluted) -$1.88

Revenue / Employee N/A

Profit / Employee $-1.32M

Employees 16